FDA approves drug to treat lupus
The Food and Drug Administration on Wednesday approved the drug Benlysta (belimumab) for the treatment of lupus, a chronic, potentially fatal autoimmune disease that affects about 5 million people across the world and, specifically, about 1.5 million Americans.
“This is a historic day for the millions of people with lupus and their families around the world who have waited more than 52 years for a treatment breakthrough for lupus," said Sandra C. Raymond, president and chief executive officer of the Lupus Foundation of America, in a statement. "Today marks the beginning of a new era of improved diagnosis, prevention, and treatment for the disease.---
Time: 1:04:43
Distance: 7.69 miles
Pace: 8:24
Calories: 1140
Weather: 46.9 degrees, humidity 68%
No comments:
Post a Comment